Prolastin is primarily used to treat which condition?

Prolastin is primarily used to treat generic emphysema that is specifically caused by a deficiency in the protein alpha-1 antitrypsin (AAT). AAT is a protease inhibitor that plays a critical role in protecting the lungs from damage caused by enzymes such as neutrophil elastase. In individuals who have a deficiency of this protein, there is an increased risk of lung damage, leading to conditions like emphysema. Prolastin works by providing the deficient protein, which can help to prevent further lung damage and alleviate symptoms associated with AAT deficiency.

In contrast, chronic bronchitis, asthma, and chronic obstructive pulmonary disease (COPD) are typically treated with different classes of medications, such as bronchodilators, corticosteroids, and other therapies aimed at managing inflammation and airway obstruction rather than addressing a specific protein deficiency like AAT. Thus, Prolastin’s unique indication for use makes it particularly relevant for those experiencing emphysema due to this genetic deficiency.